TLR9-IN-1 is a potent and selective TLR9. TLR9-IN-1 can be used for researching diseases associated with undesirable immune response[1].
TLR9-IN-1 (compound no.29) (0-10 μM; 24 h) exhibits moderately inhibitory activity against IL-1b with an IC50 of 1.61 μM in human monocytes (co-incubated with TLR8 agonist ORN8L, RNA oligonucleotide)[1].
[1]. Albert Frederick Candia, et al. Toll-like receptor antagonist compounds and methods of use. WO2018089695
















